# Viyash Scientific Limited (VIYASH)

> VIYASH closed at ₹218.39 on 30 Oct 2026, trailing P/E 55.7, market cap ₹9,540 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Viyash Scientific Limited (NSE: VIYASH) closed at ₹218.39 on 30 Oct 2026, +7.9% over one year, against a 52-week range of ₹178.13 – ₹298.00.

In the quarter ended 30 Jun 2026 (consolidated, filed 11 Aug 2026) it reported revenue of ₹946 cr and net profit of ₹66 cr, a 7.0% net margin; revenue grew 114.4% and profit grew 340.5% year on year.

On four consecutive filed quarters its trailing P/E is 55.7; since 20 May 2025 its own P/E has ranged from 50.8 to 499.8 (median 333.8), and today's reading is higher than 1% of those 358 trading days.

From the balance sheet dated 31 Mar 2026: return on equity 9.1%, ROCE 13.6%, debt-to-equity 0.15, Piotroski F-score 6 of 9.

Against 65 Healthcare peers on NSE: Net margin higher than 16% of 63 sector peers; PBT margin higher than 19% of 63 sector peers; ROE higher than 21% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹218.39 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -11.2% / +5.4% / +7.9% |
| 52-week low – high | ₹178.13 – ₹298.00 |
| Market capitalisation | ₹9,540 cr |
| Trailing P/E | 55.7 |
| Price / book | 3.28 |
| EV / EBITDA | 16.4 |
| Earnings yield | 1.8% |
| TTM EPS | ₹3.92 |
| TTM net profit | ₹171 cr |
| Quarter revenue | ₹946 cr |
| Quarter net profit | ₹66 cr |
| Net margin | 7.0% |
| Revenue growth (YoY) | +114.4% |
| Profit growth (YoY) | +340.5% |
| Return on equity | 9.1% |
| ROCE | 13.6% |
| Debt / equity | 0.15 |
| Current ratio | 2.38 |
| Free cash flow | ₹188 cr |
| Piotroski F-score | 6 / 9 |
| Average daily turnover (50 days) | ₹60.4 cr |

## Questions

### What is the P/E ratio of Viyash Scientific Limited?

Viyash Scientific Limited's trailing P/E is 55.7, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 20 May 2025 its P/E has ranged 50.8–499.8.

### What were Viyash Scientific Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Viyash Scientific Limited reported revenue of ₹946 cr and net profit of ₹66 cr (consolidated), filed with the exchange on 11 Aug 2026.

### What is Viyash Scientific Limited's ROE?

Return on equity is 9.1% based on the balance sheet dated 31 Mar 2026.

### Does Viyash Scientific Limited have debt?

Debt-to-equity is 0.15 on the balance sheet dated 31 Mar 2026.

### What is VIYASH's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, VIYASH traded between ₹178.13 and ₹298.00.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/VIYASH

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._